Boston Scientific to acquire Baylis Medical for $1.75B

Boston Scientific has entered a definitive agreement to acquire Baylis Medical Company Inc. for $1.75 billion upfront, adding transseptal platforms and left heart access products to its electrophysiology and structural heart portfolios.

“The acquisition will expand the Boston Scientific electrophysiology and structural heart product portfolios to include the radiofrequency (RF) NRG ® and VersaCross ® Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access.”news.bostonscientific.com

• 1 source
• news.bostonscientific.comBoston Scientific Announces Agreement to Acquire Baylis Medical Company Inc.Oct 6, 2021

Summarized from public sources; check the original articles before acting on it.